Patients’ compliance to home nebulizer therapy for children’s asthma in China

Trial Identifier: D5252R00001
Sponsor: AstraZeneca
NCTID:: NCT03156998
Start Date: July 2017
Primary Completion Date: May 2018
Study Completion Date: May 2018

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China, Anhui Bengbu, Anhui, China
China, Anhui Hefei, Anhui, China
China, Gansu Lanzhou, Gansu, China
China, Guangdong Guangzhou, Guangdong, China
China, Jiangsu Nanjing, Jiangsu, China, 210008
China, Jiangsu Nanjing, Jiangsu, China
China, Jiangsu Wuxi, Jiangsu, China
China, Jiangsu Xuzhou, Jiangsu, China
China, Jiangxi Nanchang, Jiangxi, China
China, Liaoning Shenyang, Liaoning, China
China, Sichuan Chengdu, Sichuan, China
China, Tianjin Tianjin, China